Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

The US struck a framework trade agreement with the European Union on Sunday (July 27), imposing a 15 per cent import tariff ...

The U.S. struck a framework trade agreement with the European Union on Sunday, imposing a 15% import tariff on most EU goods ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...

European Commission president said 15 per cent was the "best we could get". Read more at straitstimes.com. Read more at ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Miah’s decade-long battle to be at peace with her body – which she says is due to health concerns rather than body image – has seen her explore a rollercoaster of weightloss methods, from fad diets to ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.